yahoo_financeOriginal article
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery
Positive
AI Analysis
Summary
eXoZymes received a $2 million NIH grant to advance cannabinoid analogs for drug discovery applications. The funding supports the company's research and development efforts in this therapeutic area.
Outcome Details
$2 Million NIH Grant awarded
Importance:3/10
Sentiment:
0.60
NIH GrantFundingCannabinoid ResearchDrug Discovery
Related Companies
Read the original article
Published by yahoo_finance on June 24, 2026 8:10 PM